In a post in the Global Health Technologies Coalition’s “Breakthroughs” blog, part of a “new blog series to highlight the impact of USAID’s commitment to global health research and development (R&D),” Natalie Nelson, a tuberculosis (TB) survivor from Tennessee, in a Q&A calls for USAID to expand its support for health R&D to include TB vaccine research so “the agency [can] help change the lives of TB patients like her worldwide.” She discusses her personal experience with TB, reflects on “the growing issue of resistance to currently available TB treatment options,” and examines “how … new and improved vaccines — as well as treatment options — [could] help in the fight against TB worldwide,” among other topics (Lufkin, 12/18).